This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Chen, W. H. Articles by Cross, A. S. Search for Related Content PubMed PubMed Citation Articles by Chen, W. H. Articles by Cross, A. S. Social Bookmarking                   What's this?

Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA, wchen{at}medicine.umaryland.edu

Tae Jin Kang

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA

Apurba K. Bhattacharjee

Walter Reed Army Institute of Research, Silver Spring, Maryland, USA

Alan S. Cross

Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA

When given passively or elicited actively, antibodies induced by a detoxified Escherichia coli J5 mutant lipopolysaccharide (J5dLPS)-group B meningococcal outer membrane protein (-OMP) vaccine previously protected animals from lethal sepsis. To assess the use of this vaccine for the treatment of Gram-negative bacillary pneumonia, we vaccinated mice, with or without the adjuvant CpG, by intranasal (i.n.) or intraperitoneal (i.p.) routes of administration. Local and systemic IgG levels were 2—3 logs higher following i.p. immunization compared to i.n. However, i.n. immunization elicited both local and systemic IgA, unlike i.p. administration. The addition of CpG to the vaccine, by either route of administration, elicited greater levels of antibody. Intranasal immunization protected mice against lethal heterologous Gram-negative bacillary pneumonia and post-immunization serum and broncho-alveolar lavage fluid mediated enhanced bacterial killing with peritoneal and alveolar macrophages in vitro. We conclude that further studies on the use of J5dLPS-OMP for the prevention of nosocomial pneumonia are warranted.

Key Words: Sepsis • endotoxin • vaccine • mucosal immunity • pneumonia

Innate Immunity, Vol. 14, No. 5, 269-278 (2008)
DOI: 10.1177/1753425908095959


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?